{
  "case_id": "Case004_09",
  "ranked_differential_diagnosis": [
    {
      "rank": 1,
      "label": "Normal hearing sensitivity",
      "rationale_short": "Pure-tone thresholds are within normal limits (0-10 dB HL) across standard frequencies bilaterally, with excellent speech recognition scores and normal middle ear function."
    }
  ],
  "investigations_and_interpretations": {
    "ordered_list": [
      {
        "action": "Pure-tone audiometry",
        "urgency": "routine",
        "rationale_short": "To establish baseline hearing thresholds across standard and extended high frequencies prior to ototoxic chemotherapy."
      },
      {
        "action": "Speech audiometry",
        "urgency": "routine",
        "rationale_short": "To assess speech recognition thresholds and word recognition abilities as part of the baseline evaluation."
      },
      {
        "action": "Tympanometry",
        "urgency": "routine",
        "rationale_short": "To evaluate middle ear function and rule out conductive pathology."
      },
      {
        "action": "Acoustic reflexes",
        "urgency": "routine",
        "rationale_short": "To assess the integrity of the acoustic reflex arc and check for retrocochlear pathology."
      }
    ],
    "expected_interpretations_by_visit": [
      {
        "visit_id": "V1",
        "collective_interpretation": "The patient demonstrates normal hearing sensitivity bilaterally across the standard frequency range (250–8000 Hz) with excellent speech discrimination. Extended high-frequency baselines (9–16 kHz) were successfully recorded for ototoxicity monitoring. Middle ear function is normal with present acoustic reflexes.",
        "tests": [
          {
            "name": "Pure-tone audiometry",
            "category": "Audiometry",
            "result_summary": "Normal thresholds (0-10 dB HL) from 250-8000 Hz bilaterally. High-frequency thresholds (9-16 kHz) recorded: Right ear 15-40 dB HL; Left ear 20-40 dB HL."
          },
          {
            "name": "Speech audiometry",
            "category": "Audiometry",
            "result_summary": "SRT Right 7 dB HL, Left 5 dB HL. WRS 100% at 55 dB HL bilaterally."
          },
          {
            "name": "Tympanometry",
            "category": "Immittance",
            "result_summary": "Type A tympanograms bilaterally (Right: 0.3 mmho, -5 daPa; Left: 0.4 mmho, 10 daPa)."
          },
          {
            "name": "Acoustic reflexes",
            "category": "Immittance",
            "result_summary": "Ipsilateral and contralateral reflexes present at normal levels (500-4000 Hz). Reflex decay negative."
          }
        ]
      }
    ]
  },
  "treatment_and_management": {
    "proposed_items": [
      "Hearing protection use at work",
      "Serial hearing monitoring (prior to next cisplatin dose)"
    ],
    "counseling_actions": [
      "Counseled on normal baseline hearing results.",
      "Provided information regarding cisplatin ototoxicity (potential hearing loss and tinnitus).",
      "Advised to have hearing checked prior to the next dose of cisplatin to monitor for changes.",
      "Educated on the synergistic risk of noise exposure and ototoxic medication.",
      "Recommended diligent use of hearing protection at her job in the cheese production facility."
    ]
  },
  "escalation_and_red_flags": {
    "red_flags_present": [],
    "escalation": {
      "urgency": "soon",
      "destination": "Audiology",
      "rationale_short": "Patient requires serial monitoring prior to her next chemotherapy dose to detect any ototoxic changes."
    }
  },
  "follow_up_plan": {
    "timeline": "Prior to next dose of cisplatin",
    "objective": "Monitor hearing thresholds for signs of ototoxicity."
  },
  "expected_outcome": []
}